Founded in 2004, MIG Capital has grown into one of Germany's leading venture capital investors. MIG invests in early-stage deep tech and life sciences companies in German-speaking Europe and beyond. The firm has invested over €680 million in around 50 companies to date.
MIG's portfolio companies develop innovations in areas including biopharmaceuticals, energy and environmental technologies, advanced computing, digitalization/IoT, medical technology and digital health.
The investment portfolio currently consists of 32 companies.
